:::

詳目顯示

回上一頁
題名:Add-on Subanesthetic Ketamine in Electroconvulsive Therapy: A Case Report of a Patient with Bipolar Depression
書刊名:Taiwanese Journal of Psychiatry
作者:Hsu, Tien-weiPan, Chih-chuanChen, Chen-hsiuChang, Cheng-ho
出版日期:2020
卷期:34:2
頁次:頁94-95
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:4
期刊論文
1.Ritter, P.、Findeis, H.、Bauer, M.(2020)。Ketamine in the treatment of depressive episodes。Pharmacopsychiatry,53,45-50。  new window
2.Li, D. J.、Wang, F. C.、Chu, C. S.(2017)。Significant treatment effect of add-on ketamine anesthesia in electroconvulsive therapy in depressive patients: a meta-analysis。Eur Neuropsychopharmacol,27,29-41。  new window
3.Weiner, R. D.、Reti, I. M.(2017)。Key updates in the clinical application of electroconvulsive therapy。Int Rev Psychiatry,29,54-62。  new window
4.Fava, M.(2003)。Diagnosis and definition of treatment-resistant depression。Biol Psychiatry,53,649-659。  new window
5.Conway, C. R.、George, M. S.、Sackeim, H. A.(2017)。Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough。JAMA Psychiatry,74,9-10。  new window
6.Nemeroff, C. B.(2018)。Ketamine: quo vadis?。Am J Psychiatry,175,297-299。  new window
7.Loo, C.(2018)。Can we confidently use ketamine as a clinical treatment for depression?。Lancet Psychiatry,5,11-12。  new window
8.Fond, G.、Loundou, A.、Rabu, C.(2014)。Ketamine administration in depressive disorders: a systematic review and meta-analysis。Psychopharmacology,231,3663-3676。  new window
9.Fava, M.、Freeman, M. P.、Flynn, M.(2018)。Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)。Mol Psychiatry。  new window
10.Romeo, B.、Choucha, W.、Fossati, P.(2015)。Meta-analysis of short- and midterm efficacy of ketamine in unipolar and bipolar depression。Psychiatry Res,230,682-688。  new window
11.Thomas, R. K.、Baker, G.、Lind, J.(2018)。Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness。J Psychopharmacol,32,1110-1117。  new window
12.Singh, J. B.、Fedgchin, M.、Daly, E. J.(2016)。A double-blind, randomized, placebocontrolled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression。Am J Psychiatry,173,816-826。  new window
13.李文貴、張信義(20090300)。Monitoring the Seizure Efficacy during Electroconvulsive Therapy。Taiwanese Journal of Psychiatry,23(1),4-13。new window  new window
14.Fava, M.、Freeman, M. P.、Flynn, M.(2018)。Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)。Brain Stimul,11,75-84。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE